THE PROOF · US VALIDATION
10+ years. 6 farms.One consistent result.
Florida, Colorado, Kentucky. Conventional and certified organic. This isn’t a deck built on projections — it’s a decade of commercial validation involving hundreds of cows, of every genetics and parity, paused through COVID, and now looking for its first few UK postcodes to bring the innovation to where it can do the most good.
For decades, the sciencehas been pointing towards intake.
Here’s something most people miss. Our commercial trials aren’t the only evidence that intake is the lever — they sit on top of a mountain of independent science the industry has been building for decades. Just as producers vote with pounds spent and investors vote with capital deployed, scientists have been voting with their own hard-won currency: research time.
Across countless peer-reviewed papers, intake keeps turning up in the background — and when you put it at the centre, it becomes the single variable that best predicts the outcome of nearly every study, whatever the subject. When researchers measuring metabolic health, fertility, or disease look at study performance based on intake groups of High-DMI, Medium-DMI, and Low-DMI cows, they find the same thing: cows with high dry matter intake outperform the rest. They weren’t testing our device. They were, without meaning to, documenting why it works.
It’s the same logic as the chequebook on the cost page. When an entire scientific field independently keeps landing on intake as the key, that convergence is its own form of third-party proof. We didn’t invent the importance of intake — decades of science did. We built the first tool designed to act on it.
Framing draws on the breadth of transition-cow literature (Transition Period Updated review, J. Dairy Sci. 2021; NEB & disease syntheses; EFSA 2023).
Why you cantrust it.
Every result came from a matched-control design: test and control cows shared genetics, parity, calving date, feed, pen, and management — so the device was the only variable that differed. Results were tracked across the full 305-day lactation, not just the 21 days of use, across breeds, parities, and calving seasons. The core mechanism is protected by a US patent.
Ten years of US validation. Now we need UK data to justify the company’s relocation — that is the honest truth of where we are.
The results,at their conservative floor.
Both conventional and certified organic systems. Trial results are from commercial deployments, not peer-reviewed studies.
What it’s worth,per 1,000 cows.
You’ve seen the 10% floor on every page so far. You’ve read this far — so here’s the reward: the very same trials reached as high as 16% more milk across the full lactation. Both numbers, on the same per-1,000-cows-per-year basis, milk valued at AHDB ~£0.36/L (an assumption, stated as such).
at a 10% increase
at a 16% increase
Floor and ceiling reflect the observed commercial range (10–16% uplift). Conservative floor is the headline; ceiling shown as upside per stats-discipline. Milk price is an assumption (AHDB ~£0.36/L), not a guarantee.
The proof is American. The next data points are British — yours.
The Free Trial →